Article
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic…
Journal of Inflammation Research · 2024 · Li N, Hao L, Li S, Deng J, Yu F, Zhang J, Nie A, Hu X
Key facts
| Title | The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease |
|---|---|
| First author | Li N, Hao L, Li S, Deng J, Yu F, Zhang J, Nie A, Hu X |
| Journal | Journal of Inflammation Research |
| Published | Nov 3, 2024 |
| DOI | 10.2147/JIR.S490418 |
| Devices mentioned | K183168 |
| Product codes mentioned | KWP, KWQ, NKB |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1